159 related articles for article (PubMed ID: 22059453)
1. Caffeine is protective in patients with non-alcoholic fatty liver disease.
Birerdinc A; Stepanova M; Pawloski L; Younossi ZM
Aliment Pharmacol Ther; 2012 Jan; 35(1):76-82. PubMed ID: 22059453
[TBL] [Abstract][Full Text] [Related]
2. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
Park GJ; Wiseman E; George J; Katelaris PH; Seow F; Fung C; Ngu MC
J Gastroenterol Hepatol; 2011 Sep; 26(9):1411-6. PubMed ID: 21557768
[TBL] [Abstract][Full Text] [Related]
4. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
Ong JP; Pitts A; Younossi ZM
J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
[TBL] [Abstract][Full Text] [Related]
5. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
Abid A; Taha O; Nseir W; Farah R; Grosovski M; Assy N
J Hepatol; 2009 Nov; 51(5):918-24. PubMed ID: 19765850
[TBL] [Abstract][Full Text] [Related]
6. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
[TBL] [Abstract][Full Text] [Related]
8. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
9. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery.
Anty R; Marjoux S; Iannelli A; Patouraux S; Schneck AS; Bonnafous S; Gire C; Amzolini A; Ben-Amor I; Saint-Paul MC; Mariné-Barjoan E; Pariente A; Gugenheim J; Gual P; Tran A
J Hepatol; 2012 Nov; 57(5):1090-6. PubMed ID: 22820478
[TBL] [Abstract][Full Text] [Related]
10. Beverage intake among preschool children and its effect on weight status.
O'Connor TM; Yang SJ; Nicklas TA
Pediatrics; 2006 Oct; 118(4):e1010-8. PubMed ID: 17015497
[TBL] [Abstract][Full Text] [Related]
11. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
[TBL] [Abstract][Full Text] [Related]
12. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
[TBL] [Abstract][Full Text] [Related]
13. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
14. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
Zhou WD; Yang YL; Che ZH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
Kang H; Greenson JK; Omo JT; Chao C; Peterman D; Anderson L; Foess-Wood L; Sherbondy MA; Conjeevaram HS
Am J Gastroenterol; 2006 Oct; 101(10):2247-53. PubMed ID: 17032189
[TBL] [Abstract][Full Text] [Related]
16. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
[TBL] [Abstract][Full Text] [Related]
17. Clinical predictors of fibrosis in patients with chronic liver disease.
Stepanova M; Aquino R; Alsheddi A; Gupta R; Fang Y; Younossi Z
Aliment Pharmacol Ther; 2010 May; 31(10):1085-94. PubMed ID: 20175770
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.
Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T
Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839
[TBL] [Abstract][Full Text] [Related]
20. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
